Sandbox Reserved 899: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Sandbox_reserved_Karen_Glass_2020}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_reserved_Karen_Glass_2020}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==CYP2C9 A477T (*30) variant with losartan(Sunsik)== | ==CYP2C9 A477T (*30) variant with losartan(Sunsik)== | ||
<StructureSection load=' | <StructureSection load='3dai' size='340' side='right' caption='ATAD2 bromodomain' scene=''> | ||
This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
| Line 10: | Line 10: | ||
== Relevance == | == Relevance == | ||
[[Image:3dai.mp4]] | |||
== Structural highlights == | == Structural highlights == | ||
Latest revision as of 22:39, 3 March 2020
| This Sandbox is Reserved from Jan 13 through July 31, 2020 for use in the course Protein Structure in Drug Discovery taught by Karen C. Glass at the ACPHS, Colchester, United States. This reservation includes Sandbox Reserved 895 through Sandbox Reserved 901. |
To get started:
More help: Help:Editing |
CYP2C9 A477T (*30) variant with losartan(Sunsik)
| ||||||||||||
